BioTrack Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
8
- Investments
-
166
- Portfolio
-
106
- Exits
-
36
BioTrack Capital General Information
Company Description
Founded in 2017, BioTrack Capital is a venture capital firm based in Shanghai, China. The firm is seeks to invest in early-stage biotech, medtech as well as healthcare cross disciplinary sectors such as artificial intelligence and digital healthcare, consumer healthcare and related.
Business Details
Website
biotrackcapital.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- HKRI Taikoo Hui, Number 288, Shimen Road Number 1
- Unit 601-602, 6th Floor, Tower 1
- Shanghai, 200041
- China
BioTrack Capital Investments (166)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Taiyi Quantum Computing | 10-Oct-2026 | Early Stage VC | Software Development Applications | Generating Revenue | ||
| Convergen | 19-Aug-2026 | Discovery Tools (Healthcare) | Generating Revenue | |||
| Cogleap.AI | 22-Jun-2026 | Automation/Workflow Software | Generating Revenue | |||
| Restora | 18-Jun-2026 | Therapeutic Devices | Startup | |||
| Taiyi Quantum Computing | 17-Jun-2026 | Software Development Applications | Generating Revenue | |||
| TanShengWanWu | 12-Jun-2026 | Alternative Energy Equipment | Generating Revenue | |||
| Lync Bio | 19-May-2026 | Drug Discovery | Generating Revenue | |||
| Valgen Medtech | 13-May-2026 | Surgical Devices | Generating Revenue | |||
| Huihe Healthcare | 01-Apr-2026 | Secondary Transaction - Private | Surgical Devices | Generating Revenue | ||
| Syneron | 31-Mar-2026 | Early Stage VC | Drug Discovery | Generating Revenue |
BioTrack Capital Exits (36)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| BlossomHill Therapeutics | 06-Aug-2026 | IPO | |
| NuProbe | 17-Jun-2026 | ||
| Wecare Probiotics | 09-Feb-2026 | ||
| QL Biopharm | 12-Jan-2026 | ||
| Shenzhen Edge Medical | 08-Jan-2026 | ||
| CF PharmTech | 08-Oct-2025 | ||
| LaNova Medicines | 20-Aug-2025 | ||
| Guangzhou Innogen Pharmaceutical Group Co | 14-Aug-2025 | ||
| Raynovent | 31-Jul-2025 | Secondary Transaction - Private | |
| QL Biopharm | 31-Dec-2024 | Secondary Transaction - Private |
BioTrack Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
BioTrack Capital Investments by Industry, Year, and Region
BioTrack Capital Co-Investors (197)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Qiming Venture Partners | 8 |
|
|
||
| LAV (Lilly Asia Fund) |
|
|
|||
| OrbiMed |
|
|
|||
| HSG (Hong Kong) |
|
|
|||
| Highlight Capital |
|
|
BioTrack Capital FAQs
-
What is BioTrack Capital?
Founded in 2017, BioTrack Capital is a venture capital firm based in Shanghai, China.
-
When was BioTrack Capital founded?
BioTrack Capital was founded in 2017.
-
Where is BioTrack Capital headquartered?
BioTrack Capital is headquartered in Shanghai, China.
-
What is BioTrack Capital's total asset value?
BioTrack Capital has around in total assets under management.
-
How many investments has BioTrack Capital made?
BioTrack Capital has made 166 investments.
-
What has BioTrack Capital invested in?
BioTrack Capital has made numerous investments in companies like Taiyi Quantum Computing, Convergen, and Cogleap.AI within the Software Development Applications, Discovery Tools (Healthcare), and Automation/Workflow Software industries.
-
What has BioTrack Capital invested in recently?
BioTrack Capital's latest investment was on 10-Oct-2026 in Taiyi Quantum Computing, a company within the Software Development Applications industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process